Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Merck & Co., Inc.
Report date March 20, 2006 · Filed March 21, 2006
Section 16 reporting ended · disclosed 2006-03-21. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2005 Filed Dec 2, 2005 23:08 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 4,920 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-05-000093 · gin498.xml · derivative · entry 3 GINGERELLA DOUGLAS F · CIK 0001238300 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,920 Underlying: Common Shares · 4,920 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Not Applicable. F5 · price: Not Applicable. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: Not Applicable. Read SEC document |
| December 01, 2005 Filed Dec 2, 2005 23:08 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 2,109 | $19.05 | $40,176.45 |
DisclosureSEC source: 0000310158-05-000093 · gin498.xml · nonDerivative · entry 2 GINGERELLA DOUGLAS F · CIK 0001238300 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,913 Read SEC document |
| December 01, 2005 Filed Dec 2, 2005 23:08 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 4,920 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-05-000093 · gin498.xml · nonDerivative · entry 1 GINGERELLA DOUGLAS F · CIK 0001238300 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
| April 25, 2005 Filed Apr 27, 2005 19:45 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (right to buy) · Derivative | 85,000 | Not disclosed Strike: $20.70 | Not disclosed |
DisclosureSEC source: 0000310158-05-000018 · gin475.xml · derivative · entry 2 GINGERELLA DOUGLAS F · CIK 0001238300 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Shares · 85,000 shares Expires 2015-04-24 F6 · price: Not Applicable. F5 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan, exercisable in one-third increments on April 26 of each 2006, 2007 and 2008. Read SEC document |
| April 25, 2005 Filed Apr 27, 2005 19:45 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantDeferred Stock Unit Award · Derivative | 17,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-05-000018 · gin475.xml · derivative · entry 1 GINGERELLA DOUGLAS F · CIK 0001238300 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,840 Underlying: Common Shares · 17,000 shares Expires not disclosed F1 · derivative.exercise_price: Not Applicable. F4 · price: Not Applicable. F2 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan. All of the shares become deliverable on April 25, 2008. F3 · derivative.expiration_date: Not Applicable. Read SEC document |
| December 01, 2004 Filed Dec 3, 2004 14:52 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 6,560 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001223203-04-000266 · gin438.xml · derivative · entry 3 GINGERELLA DOUGLAS F · CIK 0001238300 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,840 Underlying: Common Shares · 6,560 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Not Applicable. F5 · price: Not Applicable. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: Not Applicable. Read SEC document |
| December 01, 2004 Filed Dec 3, 2004 14:52 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 2,812 | $18.41 | $51,768.92 |
DisclosureSEC source: 0001223203-04-000266 · gin438.xml · nonDerivative · entry 2 GINGERELLA DOUGLAS F · CIK 0001238300 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,102 Read SEC document |
| December 01, 2004 Filed Dec 3, 2004 14:52 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 6,560 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001223203-04-000266 · gin438.xml · nonDerivative · entry 1 GINGERELLA DOUGLAS F · CIK 0001238300 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
| June 21, 2004 Filed Jun 24, 2004 00:30 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (right to buy) · Derivative | 55,000 | Not disclosed Strike: $16.80 | Not disclosed |
DisclosureSEC source: 0000310158-04-000082 · gin419.xml · derivative · entry 2 GINGERELLA DOUGLAS F · CIK 0001238300 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Shares · 55,000 shares Expires 2014-06-20 F6 · price: Not Applicable. F5 · derivative.exercise_date: Options were granted on June 21, 2004, exercisable in one-third increments on June 22 of each 2005, 2006 and 2007. Read SEC document |
| June 21, 2004 Filed Jun 24, 2004 00:30 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantDeferred Stock Unit Award · Derivative | 5,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-04-000082 · gin419.xml · derivative · entry 1 GINGERELLA DOUGLAS F · CIK 0001238300 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,400 Underlying: Common Shares · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Not Applicable. F4 · price: Not Applicable. F2 · derivative.exercise_date: Granted under the Stock Incentive Plans. These awards vest and are 100% distributable on June 21, 2007. F3 · derivative.expiration_date: Not Applicable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.